TABLE 2

Kinetics of TPA023 t-butyl hydroxylation and N-deethylation in the presence of human liver microsomes and recombinant CYP3A4 and CYP3A5




Pooled CYP3A5-Rich Human Liver Microsomes (n = 3)

Pooled CYP3A5-Deficient Human Liver Microsomes (n = 3)

CYP3A4 + OR

CYP3A5 + OR + b5
t-Butyl hydroxylation (M1)
    Best model fit Multienzymea Inhibition Inhibition Biphasic
    Vmaxb (or Vmax1) 239 ± 11 249 ± 11 75 ± 4
    Km (or Km1) 3.4 ± 1.1 5.7 ± 0.7 3.0 ± 0.4 1.3 ± 0.1
    Vmax2 235 ± 15
    Km2 12.7 ± 0.6 18.9 ± 3.6
    Ksi 185 ± 25 167 ± 22
    CLintc 0.042 0.083 0.058
N-Deethylation (M2)
    Best model fit Multienzyme Hyperbolic Hyperbolic Biphasic
    Vmax (or Vmax1) 366 ± 3 220 ± 3 22 ± 3
    Km (or Km1) 4.5 ± 2.0 7.5 ± 0.4 3.7 ± 0.3 0.6 ± 0.2
    Vmax2 404 ± 40
    Km2 40.0 ± 1.8 82.3 ± 12.6
    Ksi
    CLin

0.049
0.059
0.037
  • a The values of Vmax, Ksi, and/or CLint in a multienzyme system were not estimated.

  • b The unit for the Vmax value was pmol/min/mg protein for human liver microsomes and pmol/min/nmol P450 for recombinant P450 enzymes. The unit for the Km value was μM. Values are the mean ± S.E.

  • c Calculation of the in vitro intrinsic clearance (CLint): hyperbolic model, CLint = Vmax/Km; and substrate inhibition model, CLint = Vmax/Km; biphasic model, CLint = Vmax1/Km1 (high affinity, low capacity). The unit for the CLint value determined in human liver microsomes and in recombinant P450 was ml/min/mg protein and ml/min/nmol, respectively.